Company Revelation Biosciences, Inc. Nasdaq
Equities
REVBU
US76135L2007
Biotechnology & Medical Research
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Rolke
CEO | Chief Executive Officer | 55 | 30/04/20 |
Chester Zygmont
DFI | Director of Finance/CFO | 44 | 30/04/20 |
Sandra Vedrick
IRC | Investor Relations Contact | - | - |
Robin Marsden
PRN | Corporate Officer/Principal | - | 30/04/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Tidmarsh
CHM | Chairman | 64 | 30/04/20 |
Jess Roper
BRD | Director/Board Member | 59 | 30/09/20 |
James Rolke
CEO | Chief Executive Officer | 55 | 30/04/20 |
Lakhmir Chawla
BRD | Director/Board Member | 53 | 26/09/23 |
Jennifer Carver
BRD | Director/Board Member | 70 | 30/04/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,632,935 | 1,627,645 ( 99.68 %) | 0 | 99.68 % |
Company contact information
Revelation Biosciences, Inc.
4660 LaJolla Village Drive Suite 100
92122, San Diego
+650 800 3717
http://www.revbiosciences.comSector
1st Jan change | Capi. | |
---|---|---|
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |